BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 26896038)

  • 1. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepant Measurements of Maximal Left Ventricular Wall Thickness Between Cardiac Magnetic Resonance Imaging and Echocardiography in Patients With Hypertrophic Cardiomyopathy.
    Hindieh W; Weissler-Snir A; Hammer H; Adler A; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-Enhanced Echocardiographic Measurement of Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy: Comparison with Standard Echocardiography and Cardiac Magnetic Resonance.
    Urbano-Moral JA; Gonzalez-Gonzalez AM; Maldonado G; Gutierrez-Garcia-Moreno L; Vivancos-Delgado R; De Mora-Martin M; Rodriguez-Palomares JF; Evangelista-Masip A
    J Am Soc Echocardiogr; 2020 Sep; 33(9):1106-1115. PubMed ID: 32564979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
    Valente AM; Lakdawala NK; Powell AJ; Evans SP; Cirino AL; Orav EJ; MacRae CA; Colan SD; Ho CY
    Circ Cardiovasc Genet; 2013 Jun; 6(3):230-7. PubMed ID: 23690394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Webb J; Villa A; Bekri I; Shome J; Teall T; Claridge S; Jackson T; Porter B; Ismail TF; Di Giovine G; Rinaldi CA; Carr-White G; Al-Fakih K; Razavi R; Chiribiri A
    Am J Cardiol; 2017 May; 119(9):1450-1455. PubMed ID: 28267963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR.
    Florian A; Masci PG; De Buck S; Aquaro GD; Claus P; Todiere G; Van Cleemput J; Lombardi M; Bogaert J
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):702-11. PubMed ID: 22789938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
    Avegliano GP; Costabel JP; Asch FM; Sciancalepore A; Kuschnir P; Huguet M; Tobon-Gomez C; Frangi AF; Ronderos R
    Echocardiography; 2016 Mar; 33(3):431-6. PubMed ID: 26525462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of the inferior wall hypertrophy in hypertrophic cardiomyopathy patients with contrast echocardiography].
    Liu Z; Zhang W; Jing X; Xiao L; Huang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2018 Feb; 35(1):92-98. PubMed ID: 29745607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
    Bois JP; Geske JB; Foley TA; Ommen SR; Pellikka PA
    Am J Cardiol; 2017 Feb; 119(4):643-650. PubMed ID: 27956002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance interpretation of left ventricular size between echocardiography and cardiac magnetic resonance in pediatric patients with aortic/mitral regurgitation.
    Barros A; Udine M; Spurney C; Olivieri L; Loke YH
    Int J Cardiovasc Imaging; 2024 May; 40(5):1049-1057. PubMed ID: 38519822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.
    Rangel I; Gonçalves A; de Sousa C; Correia AS; Pinho T; Madureira AJ; Martins E; Cardoso JS; Macedo F; Maciel MJ
    Echocardiography; 2014 Jul; 31(6):708-15. PubMed ID: 24460546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
    Cheng S; Choe YH; Ota H; Cui C; Yin G; Lu M; Li L; Chen X; Prasad SK; Zhao S
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):597-605. PubMed ID: 29071521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular myocardial diastolic dysfunction in different kinds of cardiac hypertrophy: analysis by pulsed Doppler tissue imaging.
    Galderisi M; Severino S; Caso P; Cicala S; Petrocelli A; De Simone L; Mininni N; de Divitiis O
    Ital Heart J; 2001 Dec; 2(12):912-20. PubMed ID: 11838339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications.
    Viliani D; Pozo E; Aguirre N; Cecconi A; Olivera MJ; Caballero P; Jiménez-Borreguero LJ; Alfonso F
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1771-1780. PubMed ID: 28536896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance.
    Dweck MR; Joshi S; Murigu T; Gulati A; Alpendurada F; Jabbour A; Maceira A; Roussin I; Northridge DB; Kilner PJ; Cook SA; Boon NA; Pepper J; Mohiaddin RH; Newby DE; Pennell DJ; Prasad SK
    J Cardiovasc Magn Reson; 2012 Jul; 14(1):50. PubMed ID: 22839417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.